News
GLSWQ
0.0006
NaN%
--
Weekly Report: what happened at GLSWQ last week (0414-0418)?
Weekly Report · 4d ago
Weekly Report: what happened at GLSWQ last week (0407-0411)?
Weekly Report · 04/14 09:38
Weekly Report: what happened at GLSWQ last week (0331-0404)?
Weekly Report · 04/07 09:38
Weekly Report: what happened at GLSWQ last week (0324-0328)?
Weekly Report · 03/31 09:41
Weekly Report: what happened at GLSWQ last week (0317-0321)?
Weekly Report · 03/24 09:38
Weekly Report: what happened at GLSWQ last week (0310-0314)?
Weekly Report · 03/17 09:40
Weekly Report: what happened at GLSWQ last week (0303-0307)?
Weekly Report · 03/10 09:42
Weekly Report: what happened at GLSWQ last week (0224-0228)?
Weekly Report · 03/03 09:41
Weekly Report: what happened at GLSWQ last week (0217-0221)?
Weekly Report · 02/24 09:41
Weekly Report: what happened at GLSWQ last week (0210-0214)?
Weekly Report · 02/17 09:40
Weekly Report: what happened at GLSWQ last week (0203-0207)?
Weekly Report · 02/10 09:39
Weekly Report: what happened at GLSWQ last week (0127-0131)?
Weekly Report · 02/03 09:40
Weekly Report: what happened at GLSWQ last week (0120-0124)?
Weekly Report · 01/27 09:41
Weekly Report: what happened at GLSWQ last week (0113-0117)?
Weekly Report · 01/20 09:38
Weekly Report: what happened at GLSWQ last week (0106-0110)?
Weekly Report · 01/13 09:39
Weekly Report: what happened at GLSWQ last week (1230-0103)?
Weekly Report · 01/06 09:41
Weekly Report: what happened at GLSWQ last week (1223-1227)?
Weekly Report · 12/30/2024 09:39
Weekly Report: what happened at GLSWQ last week (1216-1220)?
Weekly Report · 12/23/2024 09:41
Weekly Report: what happened at GLSWQ last week (1209-1213)?
Weekly Report · 12/16/2024 09:42
Weekly Report: what happened at GLSWQ last week (1202-1206)?
Weekly Report · 12/09/2024 09:41
More
Webull provides a variety of real-time GLSWQ stock news. You can receive the latest news about Gelesis Hldgs Inc through multiple platforms. This information may help you make smarter investment decisions.
About GLSWQ
Gelesis Holdings, Inc. is a commercial stage biotherapeutics company built for consumer engagement. The Company focuses on advancing superabsorbent hydrogel therapeutics for chronic gastrointestinal (GI) diseases including excess weight, type two diabetes, Nonalcoholic Fatty Liver Disease (NAFLD)/ Nonalcoholic Steatohepatitis (NASH), functional constipation (FC), and inflammatory bowel disease. Its product, Plenity, is an orally administered capsule. Plenity is available by prescription via a telehealth consultation with a physician trained in weight management support, with free, unlimited follow-up visits as needed. Consumers can visit myplenity.com for online consultations. Its other pipeline candidate includes GS200 for weight loss in prediabetes and type two diabetes. It is also developing GS300 for the treatment of NAFLD and NASH, and GS500 for the treatment of Functional Constipation (FC).